Next |
home / stock / snpx / snpx message board
Subject | By | Source | When |
---|---|---|---|
I agree in principal but unless NIH funds | runncoach | investorshub | 04/14/2023 6:55:44 PM |
I don't think Bryostatin is done. I | Battle Ready | investorshub | 04/14/2023 4:34:29 PM |
If Bryostatin is done for work and I | runncoach | investorshub | 04/14/2023 4:22:05 PM |
I had only kept 1000 shares of Petros, | Battle Ready | investorshub | 04/14/2023 4:19:14 PM |
Anyone that still has shares of petros from | runncoach | investorshub | 04/14/2023 4:10:24 PM |
I didn't listen but not sure how that | runncoach | investorshub | 04/14/2023 4:08:27 PM |
On the brief recently concluded call that we | Battle Ready | investorshub | 04/14/2023 3:13:11 PM |
Yeah sure they have. Faked out everyone including | runncoach | investorshub | 04/13/2023 9:53:39 PM |
Insiders have always known this was a FAIL!!!!! | XenaLives | investorshub | 04/13/2023 9:44:06 PM |
Sorry. No I meant 1.25 isn't the real | runncoach | investorshub | 04/11/2023 5:46:17 PM |
Are you saying that you interpret the filing | Battle Ready | investorshub | 04/11/2023 4:53:36 PM |
I think the price will be a minimum | runncoach | investorshub | 04/11/2023 4:50:28 PM |
Yeah they were able to amend the previous | runncoach | investorshub | 04/11/2023 4:45:45 PM |
Does anyone know the minimum share price for | Battle Ready | investorshub | 04/11/2023 1:53:38 PM |
In fact, more than 50% of all deaths | XenaLives | investorshub | 04/04/2023 1:40:39 AM |
Thanks Doc. | runncoach | investorshub | 04/02/2023 4:59:52 PM |
I don't regularly check for markers of inflammation | Doc328 | investorshub | 04/02/2023 4:47:53 PM |
Doc, I don't if you'll be able to | runncoach | investorshub | 04/02/2023 4:24:51 PM |
I actually posted on the $AVXL page Friday | Doc328 | investorshub | 04/02/2023 2:54:55 PM |
Any thoughts on TLSA/Foralumab? | redspinelpinktopaz | investorshub | 04/02/2023 2:35:29 PM |
News, Short Squeeze, Breakout and More Instantly...
Synaptogenix Inc. Company Name:
SNPX Stock Symbol:
OTCMKTS Market:
Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for Cannabinoid-Based Drug Discovery PR Newswire Proposed Schedule III drug classification expected to de-risk Cannasoul's cannabis research and potential regulatory pathways ...
Synaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing PR Newswire NEW YORK , April 24, 2024 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company develo...
Synaptogenix Increases Stake in Innovative Psilocybin Drug Discovery Company through its Partnership with Cannasoul Analytics PR Newswire Supports IP development for novel mushroom genetics and therapeutics for multiple indications NEW YORK , April 9, 202...